CRSP CRISPR Therapeutics AG

CRISPR Therapeutics (NASDAQ:CRSP), a genome editing company focused on creating transformative medicine for serious diseases, today announced that members of its senior management team are scheduled to present at four upcoming Investor Conferences.  2018 RBC Capital Markets Global Healthcare Conference Date: Thursday, February 22, 2018 Presentation: 8:00-8:25 AM ETWebcast available under Investor Relations tab at CRISPRTx.com Barclays Global Healthcare Conference Date: Tuesday, March 13, 2018 Presentation: 3:20-3:45 PM ET  Guggenheim Conference on Disruptive Technologies in Immuno-Oncology Date: March 27th, 2018  17th Annual Needham Healthcare Conference Date: March 28th, 2018Presentation: 3:30 PM ET

About CRISPR Therapeutics CRISPR Therapeutics is a leading gene-editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. CRISPR/Cas9 is a revolutionary technology that allows for precise, directed changes to genomic DNA. The company's multi-disciplinary team of world-class researchers and drug developers is working to translate this technology into breakthrough human therapeutics in a number of serious diseases. Additionally, CRISPR Therapeutics has established strategic collaborations with Bayer AG and Vertex Pharmaceuticals to develop CRISPR-based therapeutics in diseases with high unmet need. The foundational CRISPR/Cas9 patent estate for human therapeutic use was licensed from the company's scientific founder Emmanuelle Charpentier, Ph.D. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts. For more information, please visit http://www.crisprtx.com. MEDIA CONTACT: Jennifer Paganelli WCG on behalf of CRISPR +1 347-658-8290 jpaganelli@wcgworld.com INVESTOR CONTACT: Chris Erdman +1 617.307.7227 chris.erdman@crisprtx.comChris Brinzey Westwicke Partners for CRISPR +1 339-970-2843 chris.brinzey@westwicke.com